TY  - JOUR

T1  - Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial

JO  - SKIN The Journal of Cutaneous Medicine

UR  - http://dx.doi.org/10.25251/skin.7.supp.140

PY  - 2023/03/13

AU  - Wollenberg A

AU  - Cork M

AU  - Flohr C

AU  - Bewley A

AU  - Blauvelt A

AU  - Hong C-H

AU  - Imafuku S

AU  - Schuttelaar MLA

AU  - Simpson E

AU  - Soong W

AU  - Amoudruz P et al

ED  - 

DO  - DOI: 10.25251/skin.7.supp.140

PB  - National Society for Cutaneous Medicine

VL  - 7

IS  - 2

SP  - s140

EP  - s140

Y2  - 2024/12/22

ER  -